Clinical Group
RSS Feeds Peertechz

Global Journal of Cancer Therapy  Open Access

    Executive Editor(s)

    Tsuyoshi Shirakawa
    Office Doctor
    Department of Medicine
    Kyushu University
    Japan
    t-w-r@intmed1.med.kyushu-u.ac.jp
    GJCT

    After I graduated from Kyushu University Graduate School of Medical Sciences in 2004, I started junior residency at Kyushu Medical Center and Kyushu University hospital from 2004 to 2006. Next, I worked as a senior resident at Kyushu Cancer Center hospital in 2006. Then, I researched about cancer stem cells at Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science.
    I got Diplomate, Subspeciality Board of Medical Oncology in 2012, and worked as a chief resident National Cancer Center Hospital, Tokyo. At National Cancer Center Hospital, I researched about esophageal cancer chemotherapy mainly.
    Then, I joined and worked at the department of Gastrointestinal and Clinical Oncology Division of Kyushu Cancer Center Hospital from 2013 to 2015. From 2015 to 2017, I was a head of Oncology division of Miyazaki Prefectural Miyazaki Hospital, and a main and leading member of Kyushu Medical Oncology Group and Kyushu-Yamaguchi Total Oncology Group, respectively. Now in 2018, I work in Karatsu Higashi-matsuura Medical Association Center as a doctor of internal medicine.

    Research Interest:

    Medical Oncology (Mainly Gastrointestinal Cancer), Cancer stem cell (Basic research), Palliative medicine, General Medicine, Gastroenterology, Clinical study, Multi-disciplinary coordination and multi-disciplinary study.

    Publications:

    Original articles
    Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation. Rinsho Ketsueki. 2006 Oct;47(10):1372-6.

    A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer Chemother Pharmacol (2014) 74:1207-15, DOI 10.1007/s00280-014-2597-3.

    Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital. J Palliat Care Med 2015, 5:3 http://dx.doi.org/10.4172/2165-7386.1000219.

    Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 2016 Oct; 27(9): 891-8.

    Analysis of a questionnaire survey regarding current conditions against exposure to anticancer drugs and reports of cancer chemotherapy at outpatient departments in Japan. Pharmacology & Pharmacy, 2017, 8, 140-152.

    Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res. 2012 Sep 10;318(15):1799-807.

    Human STEAP3 maintains tumor growth under hypoferric condition. Exp Cell Res. 2011 Nov 1;317(18):2582-91.

    Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases. Anticancer research 2014, 34: 215-220.

    Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. Anticancer research 2014, 34: 2035-2040.

    Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.
    Anti-Cancer Drugs 2016, 27(5): 457-63.

    Efficacy and Safety of TAS-102 in clinical practice of salvage chemotherapy for metastatic colorectal cancer. Anticancer Research 2016 Apr; 36(4): 1959-66.

    Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours. Cancer Chemother Pharmacol, 2016 Jul 15 DOI 10.1007/s00280-016-3106-7.

    Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2017 May 11 DOI: 10.1007/s10120-017-0725-6.

    Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemotherapy Pharmacology, 2017 Jun 26. DOI 10.1007/s00280-017-3371-0.

    Irinotecan mnotherapy as third-line or later treatment in advanved gastric cancer. Gastric Cancer, 21(3), 464-472 DOI 10.1007/s10120-017-0759-9.

    Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. Anticancer Drugs, 2017 Sep 12 DOI 10.1097/CAD.0000000000000562.

    Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer. Anticancer Res. 2017 Nov;37(11):6459-6468.

    Corresponding author
    Successful chemoradiotherapy for neuroendocrine tumor grade 3 arising from the mandibular gingiva: a case report and literature review. Open Journal of clinical & medical case report, Volume 2 (2016) Issue 5: 1089.

    Case reports
    A complete response to second-line chemotherapy with sunitinib of a gastrointestinal stromal tumor: A case report. Molecular and Clinical Oncology 2017 Jul; 7(1): 93-97.

    Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report. J Med Case Rep. 2012, 6:315.

    Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review. Int canc conf J. 2012 Oct DOI10.1007/s13691-012-0060-z.

    Successful Chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary artery Case Rep Oncol 2014;7:484-490.

    Successful multimodal therapy for undifferentiated carcinoma with neuroendocrine differentiation in the clival region. Int canc conf J. 2014 July DOI 10.1007/s13961-014-0179-1.

    Anti-HER2 combination chemotherapy for advanced gastric cancer associated with the Peutz-Jeghers syndrome: a case report and literature review. Int canc conf J. 2013 Nov DOI 10.1007/s13961-013-0139-1.

    Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis. Molecular and Clinical Oncology 5: 579-582, 2016.

    More Info.

    Editorial Board

    Esteban Orenes-Pinero
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia
    Spain
    eorenes@um.es
    GJCT

    Research Interest: Current Professional Activity: Fibrilación Auricular, Miocardiopatía Hipertrófica, Micrornas,Remodelado Cardíaco


    More Info.
    Dhruv Kumar
    Pharmacology, Toxicologyand Theraputics
    The University of Kansas Medical Center,
    USA
    dhruvbhu@gmail.com
    GJCT

    Research Interest: Biological Skills. Plasmid Amplification And Purification, Transformation, Transfection, Transduction,Protein Isolation, Western Blot, Cell Viability And Apoptosis Assay, FluorescenceMicroscopy, Flow Cytometry, Real-Time PCR, Tissue Processing, Tissue Culture,Immunohistochemistry, XF Flux Analyzer And Mice Handling.Biophysical Skills. A Complete Understanding Of Atomic Force Microscopy To Study IntrinsicallyUnstructured Proteins Related To Neurodegenerative Disease (Parkinson’s AndAlzheimer’s Disease).Bioinformatics Skills. Software: Python, Autodock, NCBI Software Suits, Rasmol, Clustal-X And W, VMD,Phylip, Tree View,Pymol, Arguslab And Genscan Etc. Biological Databases: Genbank, EMBL, DDBJ, Pfam, PDB, Swiss Prot, Trembl Etc. Muser Friendly With Proteomics Server Expasy.Information Technology Skills


    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute
    USA
    Kailash.Chadha@RoswellPark.org
    GJCT

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.



    More Info.
    Yatendra Kumar Satija
    Yatendra Kumar Satija Molecular Oncology Lab
    National Institute of Immunology
    USA
    yksatija@gmail.com
    GJCT

    Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

    More Info.
    Prakash Paudyal
    Department of Pharmacology
    The University of Lowa
    USA
    ppaudyal2003@yahoo.com
    GJCT

    Research Interest: Role of GPCR signaling in cancer progression and metastasis.


    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    Varun Mittal
    Hematology and Oncology
    Albert Einstein Healthcare Network
    USA
    Varun.doc7@gmail.com
    GJCT

    Research Interest: Population Based Analysis of Cancer Database, Lung Carcinoma

    More Info.
    Diana Bell
    Assistant Professor
    Department of Pathology
    MD Anderson Cancer Center
    USA
    diana.bell@mdanderson.org
    GJCT

    Research Interest: A dedicated head and neck pathologist, Bell’s research interest focuses on sinonasal and salivary gland tumors. The aim of her research is to find and apply new strategies and technologies to better understand key molecular changes during the pathogenesis of head and neck cancers, with emphasis on salivary gland and sinonasal tumors.


    More Info.
    Muzafar Ahmad Macha
    Department of Biochemistry
    Molecular Biology University Nebraska Medical Center
    USA
    muzafar.macha@unmc.edu
    GJCT

    Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


    More Info.
    Karim Essani
    Professor
    Department of Biological Sciences
    Western Michigan University
    USA
    karim.essani@wmich.edu
    GJCT
    Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
    More Info.
    Julius Strauss
    Associate Investigator
    National Cancer Institute
    Thomas Aquinas College
    USA
    julius.strauss@nih.gov
    GJCT

    Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

    More Info.
    Athanasios Papatsoris
    Urology
    Royal London Hospital
    UK
    agpapatsoris@yahoo.gr
    GJCT


    Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.

    More Info.
    Vessela Vassileva
    Research Associate
    Department of Surgery & Cancer
    UCL Cancer Institute
    UK
    vessie_vassileva@hotmail.com
    GJCT

    Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.


    More Info.
    Christopher Xin Jie Wong
    Centre for Heart Rhythm Disorders
    Royal Adelaide Hospital
    South Australia
    c.wong@adelaide.edu.au
    GJCT
    Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Patrizio Lancellotti
    Professor
    Cardiology
    University of Liege
    Belgium
    plancellotti@chu.ulg.ac.be
    GJCT

    Research Interest: New Insights Into The Development And Progression Of Aortic Valvestenosis (Thenid-¬‐PAS Study) Progression And Outcome Of Secondary Mitral Regurgitation (POMAR Registry)Radiation-¬‐Induced Heart Disease (AVRI Study): Animal Study Normal Reference Ranges For Echocardiography: Rationale, Study Design And Methodology(NORRE Study)


    More Info.
    Hamidreza Montazeri
    Assistant Professor
    University of Alberta
    Canada
    hm1@ualberta.ca
    GJCT

    Research Interest: My Research Interests Include Targeted Delivery, Sirna Silencing, Apoptosis, Cancer Treatment, Multi-Drug Resistance, And Pharmaceutics In General


    More Info.
    Mirela Sedic
    Assistant Professor
    Department of Biotechnology
    University of Rijeka
    Croatia
    msedic@biotech.uniri.hr
    GJCT

    Research Interest: Her Major Scientific Interests Include Cancer Biology And Treatment, With Particular Emphasis On Sphingolipid Signalling In Cancer.


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Grivas Nikolaos
    Associate Member of EAU
    University of Ioannina
    Greece
    ngrivas@cc.uoi.gr
    GJCT

    Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

    More Info.
    Maria Saridi
    Director Nursing
    University of Peloponnese
    Greece
    sarmar32@windowslive.com
    GJCT
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    Stefania Staibano
    Professor
    Department of Pathology
    University of Naples Federico II
    Italy
    staibano@unina.it
    GJCT

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology


    More Info.
    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna
    Italy
    letizia.polito@unibo.it
    GJCT

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


    More Info.
    Rosaria Benedetti
    Second University of Naples Italy
    Italy
    rosaria.benedetti@gmail.com
    GJCT

    Rsearch Interest: Molecular Biology, Cell Biology, Cancer Research

    More Info.
    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Haruo Sugiyama
    Professor
    Department of Functional Diagnostic Science
    Osaka University
    Japan
    sugiyama@sahs.med.osaka-u.ac.jp
    GJCT

    Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells


    More Info.
    Tsuyoshi Shirakawa
    Department of Oncology
    Miyazaki University Hospital
    Japan
    twriver1979@gmail.com
    GJCT

    Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study


    More Info.
    Manuel Aureliano
    Associate Professor
    University of Algarve
    Portugal
    maalves@ualg.pt
    GJCT

    Research Interest: Toxicology And Pharmaceutical Applications Of Decavanadate; Ii) Muscle Contraction And Regulation; Iii) Insulin Mimetic Compounds.


    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Andrey Akopov
    Professor
    Pavlov First State Medical University
    Russia
    akopovand@mail.ru
    GJCT

    Research Interest: Lung Cancer, Surgery, Neoadjuvant Therapy, Photodynamic Therapy, Targeted Therapy, Malignant Pleural Effusion, Endobronchial Therapy.


    More Info.
    Francisco Torrens
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia,
    Spain
    Francisco.Torrens@uv.es
    GJCT

    Research Interest: Theoretical Chemistry, Physical Chemistry, Mathematical Chemistry, Computational Chemistry, Molecular Modelling, Simulation, And Design, Computer-Aided Drug Design And Development, Molecular Graphics And Representation Of Molecular Properties.


    More Info.
    Abdel-Moneim Osman
    Professor
    Department of Medicine
    King Abdel-Aziz University
    Saudi Arabia
    moneimosman@hotmail.com
    GJCT
    Research Interest: Cancer Research.Pharmacology, Cell Cycle Effect, Drug-Drug Intertaction, Chemoprotection, Potentiation olf Cytotoxic Drugs
    More Info.
    Shinq-Jen Wu
    Da-Yeh University
    Taiwan
    jen@mail.dyu.edu.tw
    GJCT

    Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan


    More Info.
    Jose Maria Pereira de Godoy
    Assistant Professor
    Regional Medical School
    egional Medical School, São José do Rio Preto
    Brazil
    godoyjmp@riopreto.com.br
    GJCT
    Research Interest: Breast CancerRehabilitationLymphedema  
    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    analivia_sg@yahoo.com.br
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    Rui-An Wang
    Professor
    Department of Pathology and Pathobiology
    The Fourth Military Medical University
    China
    wangra@fmmu.edu.cn
    GJCT

    Research Interest: Theory and Mechanisms of Carcinogenesis and Metastasis; Breast Cancer; Endocrinology


    More Info.
    Gang Zhao
    Professor
    Department of Pancreatic Surgery
    Huazhong University of Science and Technology
    China
    gangzhao@aliyun.com
    GJCT
    More Info.
    Qinong Ye
    Professor
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology
    China
    yeqn66@yahoo.com
    GJCT

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response


    More Info.
    Wang Fan
    Attending Physician
    The First Peoples Hospital of Jingmen
    China
    wangfan19840303@126.com
    GJCT

    Research Interest: Glioma, Circadian Gene, Radiotherapeutic Sensitivity, Carcinogenesis

    More Info.
    Jinbo Gao
    Department of Gastrointestinal Surgery
    Huazhong University of Science and Technology
    China
    gaojinbo@163.com
    GJCT

    Research Interest:  Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase

    More Info.
    Peng Zhan
    Associate Professor
    Shandong University,
    China
    zhanpeng1982@163.com
    GJCT

    Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


    More Info.
    Hua Yang
    Department of Cell Biology
    Peking University,
    China
    yanghua@bjmu.edu.cn
    GJCT

    Research Interest: Oncology,including basic and clinical


    More Info.
    Fan Song
    Sun Yat-Sen University
    China
    fansong8888@163.com
    GJCT

    Research Interest: Minimal Invasion, Endoscopically Assisted Selective Neck Dissection, Functional Reconstruction, Mitochondrial Fission, Cisplatin Sensitivity, Mirna, Lncrna


    More Info.
    Gang Du
    Shanghai Jiaotong University
    China
    gdu@dbm.ecnu.edu.cn
    GJCT
    Research Interest: Clinical Tumour Classification And Diagnosis, Data Mining In Healthcare, Clinical Pathway Modeling, Simulation And Scheduling Optimization, Decision-Making In Healthcare  
    More Info.
    Xingding Zhang
    Assistant Professor
    Diagnosis and Nanomedicine Engineering Technology Center
    China
    ading5@hotmail.com
    GJCT

    Research Interest: Autophagy and Apoptosis


    More Info.
    Mostafa Shawky Ibrahim El-Haddad
    Assistant Professor
    Department of Clinical Oncology
    Cairo University
    Egypt
    mostafa@mostafaelhaddad.com
    GJCT

    Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Rajeev Shrivastava
    Department of Radiation Oncology
    Aditya Birla Memorial Hospital
    India
    dr_shriraj@yahoo.co.in
    GJCT

    Research Interest: Carcinoma Lung, Breast and Cervix

    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine
    India
    manzooriiim@gmail.com
    GJCT

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    Vijai Kant Agnihotri
    Scientist
    Institute of Himalayan Bioresource Technology
    India
    kantvijai@yahoo.com
    GJCT

    Research Interest: Natural Product Chemistry, Toxicology, Spectroscopy, Essential Oils

    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Mine Yarim
    Professor
    Yeditepe University
    Turkey
    myarim@yeditepe.edu.tr
    GJCT

    Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

    More Info.
    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    rkkoiri@dhsgsu.ac.in
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.

    Advertisements

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT